Jiangsu Baozong & Baoda Pharmachem Co., Ltd. (BZBD) Is invested by Hong Kong-based Raywapharma International Limited, it is a comprehensive active pharmaceutical ingredients company, with the registered capital of US$ 20 million and the total investment of US$ 90 million for the Phase I project. BZBD was established in 2006, and started commercial production in December 2007, with over 400 staffs.

The plant of BZBD, with total of 150,000 m2, is located in Jiangsu Rugao Port Economic Development Zone, by the north of the Yangze River, it is in the 1.5 hours economic circle of Shanghai with a geographical superiority within the Changjiang Delta. It was designed and built in strict compliance with the Good Manufacturing Practice of Chinese (GMP for Pharmaceutical Products and Veterinary Products), US and European Union. BZBD has implemented the ISO 9000, 14000 and 18000 standards on its own initiative.

BZBD is engaged in the development, manufacturing and the sale of Pharmaceutical Products, Veterinary Products and Fine Chemicals. The Shanghai manufacturing base of BZBD has a history of more than 30 years focused on the manufacturing of Pharmaceutical Products, Veterinary Products and Fine Chemicals, and has obtained GMP certificates of Pharmaceutical Products, Veterinary Products, as well as the COS certificates.

The products are mainly exported to US, EU and Japan, and built a long-term relationship with our clients all over the world. The company, equipped with a first-class R&D center and a quality control center.

BZBD has always been adhered to the “Safety Manufacturing, Green Manufacturing and Cleaning Manufacturing”, and devoting itself to the “Responsible to the Social and Benefiting Human Beings”. With the high sense of social responsibility and the continuous effort in technological innovations, BZBD will continue to contribute to become one of the world’s premier custom manufactures and build a long-term relationship with out customers by providing quality products with cost effective production.